Related Experiment Video
Updated: Jul 3, 2026

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
Does the preventive effect of different drugs depend on location of the atherosclerotic process?
1Department of Vascular Diseases, University Medical Center Ljubljana, Slovenia. pavel.poredos@kclj.si
Abstract:
Atherosclerosis can affect nearly any part of the arterial system. Therefore, it is considered as a generalized disease. As most probably similar or identical etiopathogenetic mechanisms are involved in different atherosclerotic diseases, a different effect of treatment of risk factors on atherosclerotic lesions in different parts of the vascular system is expected. Until now, great emphasis has been placed on the aggressive pharmacological management of coronary artery disease, less attention has been devoted to the management of cerebrovascular and much less to peripheral arterial disease, despite their significant morbidity and mortality. The data from recent trials have indicated that treatment of patients with antiplatelet drugs, statins, antihypertensive and antidiabetic drugs prevents the progression of coronary atherosclerosis, reduces cardiovascular events and improves prognosis of coronary patients. Subgroup analyses from large studies have also shown that treatment of risk factors for atherosclerosis with drugs reduces cardiovascular events and improves prognosis of cerebrovascular and peripheral arterial occlusive disease. Although some studies indicate that the effects of distinct preventive procedures are to some extent dependent on the locations of atherosclerotic disease, it seems that the success of preventive measures is mostly related to the progression of the disease or the risk of treated population and not on the treated vascular bed.
Insights
Atherosclerosis is a generalized vascular disease. Treating risk factors with medications effectively reduces cardiovascular events and improves outcomes across coronary, cerebrovascular, and peripheral arterial diseases.
Area of Science:
- Cardiovascular Medicine
- Vascular Biology
- Public Health
Background:
- Atherosclerosis affects the entire arterial system, making it a generalized disease.
- Disparities exist in managing coronary artery disease versus cerebrovascular and peripheral arterial diseases, despite similar underlying mechanisms and significant morbidity/mortality.
- Risk factor management is crucial for preventing atherosclerotic lesion progression and improving patient prognosis.
Purpose of the Study:
- To evaluate the efficacy of risk factor treatment across different vascular beds affected by atherosclerosis.
- To compare the impact of interventions on coronary, cerebrovascular, and peripheral arterial diseases.
- To determine if treatment effects are location-dependent or population-risk dependent.
Main Methods:
- Review of recent clinical trials and subgroup analyses of large studies.
- Analysis of data on the impact of antiplatelet drugs, statins, antihypertensives, and antidiabetics.
- Comparison of treatment outcomes across different atherosclerotic disease locations.
Main Results:
- Pharmacological treatment of risk factors prevents coronary atherosclerosis progression and reduces cardiovascular events.
- Risk factor management improves prognosis for patients with coronary artery disease.
- Evidence suggests similar benefits of risk factor treatment for cerebrovascular and peripheral arterial occlusive diseases, reducing cardiovascular events and improving prognosis.
Conclusions:
- Treatment of risk factors for atherosclerosis with available drugs is effective across the vascular system.
- Preventive measure success is primarily linked to disease progression and patient risk, not the specific vascular bed treated.
- Aggressive management of risk factors offers broad benefits for generalized atherosclerotic disease.
More Related Videos
Related Concept Videos
Atherosclerosis III: Management
Tissue-Drug Binding: Localization of Drugs and its Significance
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine the...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Cardiovascular Drugs: Classification based on Therapeutic Indications
Coronary Artery Disease V: Interprofessional Care

